Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
India
/
Healthcare
/
Poly Medicure
531768
Poly Medicure
Aging Populations And Medtech Trends Will Unlock Global Potential
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 6 Analysts
Published
17 Aug 25
Updated
17 Aug 25
0
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
₹2,841.99
33.1% undervalued
intrinsic discount
17 Aug
₹1,899.95
Loading
1Y
-13.5%
7D
-1.0%
Author's Valuation
₹2.8k
33.1% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
₹2.8k
33.1% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
28b
2015
2017
2019
2021
2023
2025
2027
2028
Revenue ₹28.3b
Earnings ₹5.9b
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
16.37%
Medical Equipment revenue growth rate
0.44%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
13.89%
Calculation
₹5.90b
Earnings '28
x
81.88x
PE Ratio '28
=
₹482.73b
Market Cap '28
₹482.73b
Market Cap '28
/
115.09m
No. shares '28
=
₹4.19k
Share Price '28
₹4.19k
Share Price '28
Discounted to 2025 @ 13.88% p.a.
=
₹2.84k
Fair Value '25